Table 5 Results of the mixed models’ intention to treat analyses serum concentrations 6 months after the start of the intervention (T1)
Outcome | Intervention group N = 64 | Control group N = 30 | Model A N = 94 |  |  | Model B N = 87 |  |  |
|---|---|---|---|---|---|---|---|---|
Serum concentrations | Mean (sd) | Mean (sd) | B (95% CI) | P value | d | B (95% CI) | P value | d |
IGF-I | ||||||||
 Baseline | 13.71 (4.48) | 14.16 (4.37) |  |  |  |  |  |  |
 6 months | 14.58 (4.97) | 14.47 (4.15) | 0.23 (− 0.27 to 0.74) | .36 | .05 | 0.21 (− 0.33 to 0.76) | .45 | .05 |
Insulin | ||||||||
 Baseline | 49.91 (33.74) | 54.62 (37.49) |  |  |  |  |  |  |
 6 months | 43.55 (36.30) | 46.18 (21.79) | 0.88 (− 3.50 to 5.26) | .69 | .03 | 1.44 (− 3.29 to 6.20) | .55 | .04 |
Total cholesterol | ||||||||
 Baseline | 5.34 (1.17) | 5.29 (1.11) |  |  |  |  |  |  |
 6 months | 5.40 (1.17) | 5.33 (1.02) | 0.02 (− 0.08 to 0.12) | .70 | .02 | 0.02 (− 0.09 to 0.13) | .69 | .02 |
HDL-cholesterol | ||||||||
 Baseline | 1.43 (0.44) | 1.43 (0.36) |  |  |  |  |  |  |
 6 months | 1.45 (0.45) | 1.48 (0.36) |  − 0.01 (− 0.05 to 0.02) | .46 | .02 |  − 0.01 (− 0.05 to 0.03) | .62 | .02 |
Triglycerides | ||||||||
 Baseline | 1.52 (1.04) | 1.62 (0.94) |  |  |  |  |  |  |
 6 months | 1.51 (0.88) | 1.55 (0.85) | 0.02 (− 0.08 to 0.12) | .67 | .02 | 0.02 (− 0.09 to 0.13) | .68 | .02 |